Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat.
about
Formulations of deoxycholic for therapy: a patent review (2011 - 2014).The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells.Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics.The influence of bile salts on the distribution of simvastatin in the octanol/buffer system.Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer.Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol.High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
P2860
Q38612255-451ECAB2-9787-40DE-9CE1-AA53B4B656F8Q38846334-A5F0FB29-BF72-4B98-BA41-5F9EA66366A3Q38976374-D4B71874-CB3D-4A77-806F-34CBE666A58EQ39351329-9E06ED00-74B9-4F74-BA35-71AE336A2B2AQ40703785-609C0163-9B3D-4740-87D5-3EB7CC27D3A5Q42770089-9DAA1442-6940-45DD-8F77-79326F0524D5Q42935253-228D127C-5419-4A41-859B-295CFBF6337CQ43808142-D3E568C5-E12F-4EFB-AF31-D43492FB9A30Q48089000-75CD7D31-3B55-4475-88FA-00F32E8BFD38Q48177243-A958F6F2-839F-4832-AA08-2C5A73FA2B91Q53281341-A6AD235C-0CE0-49CD-BCA4-DFE40F746DD0Q57148084-0335430F-7BED-4BDF-85DA-3C30AB197CA5
P2860
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Deoxycholic Acid as a Modifier ...... Blood Brain Barrier of a Rat.
@en
type
label
Deoxycholic Acid as a Modifier ...... Blood Brain Barrier of a Rat.
@en
prefLabel
Deoxycholic Acid as a Modifier ...... Blood Brain Barrier of a Rat.
@en
P2860
P50
P356
P1476
Deoxycholic Acid as a Modifier ...... e Blood Brain Barrier of a Rat
@en
P2093
Boris Milijašević
Velibor Vasović
P2860
P304
P356
10.1155/2013/598603
P577
2013-03-13T00:00:00Z